Document Detail


Obesity in pregnancy: problems and potential solutions.
MedLine Citation:
PMID:  21196324     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Recent years have witnessed an increase in the prevalence of maternal obesity during pregnancy in the United States and worldwide. Obese women have increased risks for gestational problems, such as diabetes, hypertension, and pre-eclampsia. Further, gestational obesity can adversely impact fetal growth and result in macrosomia, congenital abnormalities, and even fetal death. Measures must be taken to reduce maternal adiposity, as even a modest weight loss during pregnancy is beneficial for the health of mothers and fetus. Calorie restriction and moderate exercise are proven safe methods of stopping weight gain and/or inducing white-fat loss in these subjects. Additionally, therapeutic drugs that activate the AMP-activated protein kinase signaling pathway may be effective in ameliorating pathological conditions in obese patients. Finally, dietary supplementation with L-arginine or its effective precursor (L-citrulline) may be beneficial for managing overweight or obese gestating women by reducing white-fat accretion. Because of ethical concerns over human studies, animal models (e.g., sheep, pigs, baboons, rats, and mice) are warranted to test novel hypotheses with enormous biological significance and clinical applications.
Authors:
Jason R McKnight; M Carey Satterfield; Xilong Li; Haijun Gao; Junjun Wang; Defa Li; Guoyao Wu
Related Documents :
23478074 - Expression of corticotrophin-releasing hormone and its receptor in patients with intrah...
21278504 - Labor and fetal heart rate decelerations: relation to fetal metabolic acidosis.
11516164 - Induction of rabbit lung cyp4a4 prostaglandin omega-hydroxylase by various steroid horm...
21429074 - Referrals for dental care during pregnancy.
21481094 - Emergency peripartum hysterectomy in a tertiary obstetric center: nine years evaluation.
19687774 - Different periods of periconceptional undernutrition have different effects on growth, ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2011-01-01
Journal Detail:
Title:  Frontiers in bioscience (Elite edition)     Volume:  3     ISSN:  1945-0508     ISO Abbreviation:  Front Biosci (Elite Ed)     Publication Date:  2011  
Date Detail:
Created Date:  2011-01-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101485240     Medline TA:  Front Biosci (Elite Ed)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  442-52     Citation Subset:  IM    
Affiliation:
Faculty of Nutrition, Department of Animal Science, Texas A&M University, College Station, TX 77843-2471, USA. jrm001@tamu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Grant Support
ID/Acronym/Agency:
1R21 HD049449/HD/NICHD NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  NAD+ treatment decreases tumor cell survival by inducing oxidative stress.
Next Document:  HIV-1 integration site preferences in pluripotent cells.